Radioautismo.org
Benvenuto
Login

Nvic.org: inutile e pericoloso il vaccino anti pertosse

In primo piano
Loading...

Grazie! Condividilo con i tuoi amici!

URL

Non hai gradito questo video. Grazie per il feedback!

Ci dispiace, solo gli utenti registrati possono creare le playlists.
URL


Aggiunto da Admin in reazioni avverse ai vaccini
2,110 Visualizzazioni

Descrizione

Si ringrazia nvic.org -- Articolo e fonti possono essere  letti qui

 

http://www.nvic.org/nvic-vaccine-news/march-2016/pertussis-microbe-outsmarts-the-vaccines.aspx


f
onti e riferimenti

http://www.nvic.org/nvic-vaccine-news/march-2016/pertussis-microbe-outsmarts-the-vaccines.aspx

 

Click to View and Access References

 


1 MSNBC. Growing outbreaks of whooping cough raise health fears . July 28, 2010.

2 Brown M. Pertussis Outbreaks Hit West, Midwest – Again. Parents Refusal to Vaccinate Singled Out as Contributing Factor . American Academy of Family Physicians (AAFP). May 30, 2012.

3 Kerns J. Researchers: Vaccination Exemptions Linked to Increase in Whooping Cough Cases. MyNorthwest.com June 4, 2013.

4 Kotulak R. Vaccination Urged for Whooping Cough . Chicago Tribune. Nov. 17, 1985.

5 Fine PEM, Clarkson JA. The Recurrence of Whooping Cough: Possible Implications for Assessment of Vaccine Efficacy . The Lancet 1982; 1(8273): 666-669.

6 Trollfors B. Bordetella pertussis whole cell vaccines – efficacy and toxicity . Acta paediatrica Scandinavia 1984; 73(4): 417-425.

7 Transcript (partial) of May 12, 1986 ACIP Meeting discussion of DPT risks and failures. Pgs. 34-37. NVIC.org.

8 Stadlin S, Bednarczyk RA, Omer SB. Medical Exemptions to School Immunization Requirements in the United States – Association of State Policies with Medical Exemption Rates (2004-2011). J Infect Dis Aug. 29, 2012.

9 Omer SB. How to Handle the Vaccine Skeptics. The New York Times Feb. 6, 2015.

10 Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association Between Vaccine Refusal and Vaccine-Preventable Disease in the United States: A Review of Measles and Pertussis. JAMA 2016; 315(11): 1149-1158.

11 Rappaport L. Vaccine refusal tied to increased risk of measles and pertussis. Reuters Mar. 15, 2016.

12 Lavine J, Bjornstad O, de Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine . Vaccine 2012; 30(3): 544-551.

13 Cherry JD. Why Do Pertussis Vaccines Fail? Pediatrics 2012; 129(5).

14 Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014; 111(2): 787–792

15 Misegades LK, Winter K, Harriman K et al. Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010 . JAMA 2012; 308(20): 2126-2132.

16 Matthias J, Pritchard S, Martin SW et al. Sustained Transmission of Pertussis in Vaccinated, 1–5-Year-Old Children in a Preschool, Florida, USA . Emerging Infectious Diseases Jan. 15, 2016.

17 Klein NP, Bartless S, Fireman B, Baxter R.Waning Tdap Effectiveness in Adolescents. Pediatrics Feb. 3, 2016.

18 Hinman A, Orenstein WA, Schuchat A.Vaccine Preventable Diseases, Immunization and MMWR 1961-2011. MMWR Oct. 7, 2011; 60(04): 49-57.

19 CDC. Vaccination Coverage Among Children in Kindergarten – United States, 2014-15 School Year . Aug. 28, 2015: 64(33): 897-904.

20 CDC. National, State and Selected Local Area Vaccination Coverage Among Children Aged 19-36 Months – United States, 2014 . Aug. 28, 2015: 64(33): 889-896.

21 CDC. National, Regional, State and Selected Local Area Vaccine Coverage Among Adolescents Aged 13 to 17 Years – United States, 2014 . MMWR 2015; 64(29): 784-792.

22 Matthias J, Pritchard S, Martin SW et al. Sustained Transmission of Pertussis in Vaccinated, 1–5-Year-Old Children in a Preschool, Florida, USA . Emerging Infectious Diseases Jan. 15, 2016.

23 Klein NP, Bartless S, Fireman B, Baxter R.Waning Tdap Effectiveness in Adolescents. Pediatrics Feb. 3, 2016.

24 Skoff TH, Kenyon C, Cocoros N et al. Sources of Infant Pertussis Infection in the United States. Pediatrics 2015; 136(4): 635-641.

25 Bart MJ, Harris SR, Advani A et al. Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination . MBio 2014; 5(2).

26 Kallonen T, He Q. Bordetella pertussis strain variation and evolution post vaccination. Expert Rev Vaccines 2009; 8(7): 863-875.

27 Institute of Medicine. Pertussis and Rubella Vaccines: A Brief Chronology (Appendix B, pp. 320) In: Adverse Effects of Pertussis and Rubella Vaccines. The National Academies Press 1991.

28 NIH. Historical Record of Vaccine Product Licensing Holders in the United States. (Table H-1). In: The Children’s Vaccine Initiative: Achieving the Vision. The National Academy of Sciences 1993.

29 CDC. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Mar. 28, 1997;46(RR-7):1–25

30 World Health Organization. Immunization Coverage (Global). WHO September 2015.

31 CDC. Pertussis in Other Countries. Sept. 8, 2015.

32 National Center for Health Statistics. U.S. Vital Statistics Mortality Data 1940-1949. Table 2 – Death Rates for Selected Causes, Whooping Cough (All Races, Both Sexes) 1948 . Pg. 38.

33 Grove RD, Hetzel AM. Vital Statistics Rates in the United States 1940-1960. General Mortality (1921-1929), Section C, Table 65: Whooping Cough . Pg. 577. U.S. Public Health Service National Center for Health Statistics 1968.

34 CDC. 2013 Final Pertussis Surveillance Report. Aug. 15, 2014.

35 ` Bamberger ES, Srugo I. What is new in pertussis? Eur J Pediatr 2008; 167: 133-139.

36 Cherry JD. Why Do Pertussis Vaccines Fail? Pediatrics 2012; 129(5).

37 Zouari A, Smaoui H, Kechrid A. The diagnosis of pertussis: which method to choose? Crit Rev Microbiol 2012; 38(2): 111-121.

38 Van der Zee A, Schellekens JF, Mooi FR. Laboratory Diagnosis of Pertussis. Clin Microbiol Rev 2015; 28(4): 1005-10026.

39 Sutter RW, Cochi SL. Pertussis Hospitalizations and Mortality in the United States, 1985-1988: Evaluation of the Completeness of National Reporting . JAMA 1992; 267(3): 386-391.

40 Deville JG, Cherry JD, Christenson PD et al.Frequency of Unrecognized Bordetella pertussis Infections in Adults. Clin Infect Dis 1995; 12: 639-642

41 Cherry JD. The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis Infection . Pediatrics 2005; 115(5).

42 Ward JI, Cherry JD, Chang S et al.Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults. N Eng J Med 2005; 353(15): 1555-1563.

43 Long SS, Lischner HW et al.Serologic evidence of subclinical pertussis in immunized children. Pediatr Infect Dis 1990; 9(10): 700-705.

44 He Q, Viljanen MK, Nikkari S et al. Outcomes of Bordetella pertussis Infection in Different Age Groups in an Immunized Population . J Infect Dis 1994; 170: 873-877.

45 Zhang Q, Yin Z, Shao LH et al. Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study . Scand J Infect Dis 2014; 46(4): 280-287.

46 Phadke VK, Bednarczyk RA, Salmon DA, Omer SB. Association Between Vaccine Refusal and Vaccine-Preventable Disease in the United States: A Review of Measles and Pertussis. JAMA 2016; 315(11): 1149-1158.

47 Wendelboe AM, Van Rie A et al.Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(Suppl 5): S58-S61.

48 Wei SC, Tetti K, Cushing K et al. Effectiveness of Adolescent and Adult Tetanus Reduced-Dose Diphtheria and Acellular Pertussis Vaccine against Pertussis . Clin Infect Dis 2010; 51(3): 315-321.

49 Gabutti G, Azzari C, Bonanni P et al.Pertussis: Current perspectives on epidemiology and prevention. Human Vaccines & Immunotherapeutics 2015; 11(1): 108-117.

50 Coote JG. Environmental sensing mechanisms in Bordetella. Adv Microb Physiol 2001; 44: 141-181.

51 Melvin JA, Scheller EV et al. Bordetella pertussis pathogenesis: current and future challenges . Nature Reviews Microbiology 2014; 12: 274-288.

52 Hewlett EK, Burns DL Cotter PA et al.Pertussis Pathogenesis – What We Know and What We Don’t Know. J Infect Dis 2014; 209: 982-985.

53 Robbins JB, Schneerson R, Kubler-Kielb J et al. Toward a new vaccine for pertussis. PNAS 2014; 111(9): 3213-3216.

54 Riolo MA, Rohani.Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proc Nat Acad Sci 2015; 112(5): E472-477.

55 De Celles MD, Magpantay FMG et al.The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc R Soc B 2016; 283.

56 Preston NW, Stanbridge TN. Efficacy of Pertussis Vaccines: A Brighter Horizon. Brit Med J 1972; 3:448-451.

57 Broome CV, Preblud SR, Bruner B et al. Epidemiology of pertussis, Atlanta, 1977. J Pediatr 1981; 98(3): 362-267.

58 Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9(5): 866-883.

59 Greco D, Salmaso S, Mastrantonio P et al. A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine Against Pertussis . N Engl J Med 1996; 334(6): 341-348.

60 Schmitt HJ, Schuind A, Knuf M et al. Acellullar Pertussis Vaccines: The Rationale for an Efficacy Trial in Germany . J Infect Dis 1996; 174(Suppl 3): S287-S290.

61 Trollfors B. Bordetella pertussis whole cell vaccines – efficacy and toxicity . Acta paediatrica Scandinavia 1984; 73(4): 417-425.

62 CDC. Pertussis (Whooping Cough) Cases by Year (1922-2014). Sept. 8, 2015.

63 Fine PEM, Clarkson JA. The Recurrence of Whooping Cough: Possible Implications for Assessment of Vaccine Efficacy . The Lancet 1982; 1(8273): 666-669.

64 Marchant CD, Loughlin AM, Lett SM et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness . J Infect Dis 1994; 169(6): 1297-1305.

65 Tanaka M, Vitek CR, Pascual B et al.Trends in Pertussis Among Infants in the United States, 1980-1999. JAMA 2003; 290)22): 2968-2975.

66 Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection . Am J Dis Child 1978 132(4): 371-373.

67 Yih WK, Lett SM, desVignes FN et al. The increasing incidence of pertussis in Massachusetts adolescents and adults 1989-1998 . J Infect Dis 2000; 182(5): 1409-1416.

68 Christie CDC, Marx ML, Colin D et al. The 1993 Epidemic of Pertussis in Cincinnati. N Engl J Med 1994; 331: 16-21.

69 DeSerres G, Boulianne N et al. Pertussis in Quebec: ongoing epidemic since the late 1980’s . Can Commun Dis Rep 1995; 21(5): 45-48.

70 CDC. Pertussis Outbreak – Vermont, 1996. MMWR Sept. 5, 1997; 46(35): 822-826.


71 Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence form a 10 year community study . Brit Med J 1988; 296: 612-614.

72 Bouchez B, Guiso N.Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. FEMS Pathogens and Disease Aug. 4, 2015 (online).

73 Barkin RM, Pichichero ME. Diphtheria-Pertussis-Tetanus Vaccine: Reactogenicity of Commercial Products. Pediatrics 1979; 63(2).

74 Cody CL, Baraff LJ, Cherry JD et al. Nature and Rates of Adverse Reactions Associated with DTP and DT Immunizations in Infants and Children . Pediatrics 1981; 68(5).

75 Miller DL, Ross EM, Alderslade R et al.Pertussis immunization and serious acute neurological illness in children. Brit Med J 1981; 282: 1595-1599.

76 Institute of Medicine. DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis. Washington, D.C. The National Academies Press 1994.

77 CDC. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Mar. 28, 1997;46(RR-7):1–25

78 Gustafsson L, Hallander HO, Olin P et al. A Controlled Trial of a Two-Component Acellular, A Five-Component Acellular, and a Whole Cell Pertussis Vaccine . New Engl J Med1996; 334(6): 349-355.

79 Greco D, Salmaso S, Mastrantonio P et al. A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine Against Pertussis . N Engl J Med 1996; 334(6): 341-348.

80 Zhang L, Prietsch SOM et al. Acellular vaccines for preventing whooping cough in children (Review). The Cochrane Library 2014 , Issue 9.

81 Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA. 2014; 111(2): 787–792.

82 Lavine J, Bjernstad O, de Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine . Vaccine 2012; 30(3): 544-551.

83 DeGouw D, Diavatopoulos DA, Bootsma HJ et al. Pertussis: a matter of immune modulation. FEMS Microbiol Rev 2011; 35(2011): 441-474.

84 Libster R, Edwards KM. Re-emergence of Pertussis: What Are the Solutions? Expert Rev Vaccines 2012; 11(11): 1331-1346.

85 Bouchez B, Guiso N.Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. FEMS Pathogens and Disease Aug. 4, 2015 (online

86 CDC. Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR May 24, 2006;55(RR-3):1–34.

87 CDC. Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC for Use of Tdap Among Health-Care Personnel. MMWR Dec. 15, 2006; 55(RR-17): 1-37.

88 Wei SC, Tetti K, Cushing K et al. Effectiveness of Adolescent and Adult Tetanus Reduced-Dose Diphtheria and Acellular Pertussis Vaccine against Pertussis . Clin Infect Dis 2010; 51(3): 315-321.

89 Mooi FR, van Oirschot H, Heuvelman K et al. Polymorphism in the Bordetella pertussis Virulance Factors P. 69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution . Infection and Immunity 1998; 66(2): 670-675.

90 Simondon F., Guiso N.Genetic evolution under vaccine pressure: the Bordetella pertussis model. Bull Soc Pathol Exot 2000; 93(3): 202-205.

91 De Melker HE, Schellekens JFP, Neppelenbroek SE et al. Reemergence of Pertussis in the Highly Vaccinated Population of the Netherlands: Observations on Surveillance Data. Emerg Infect Dis 2000; 6(4): 348-357.

92 Mooi FR, vanLoo IHM, King AJ . Adaptation of Bordetella pertussis to vaccination: A Cause for Its Reemergence? Emerg Infect Dis 2001; 7(3): 526-528.

93 Weber C, Boursaux-Eude C, Coralie G et al. Polymorphism of Bordetella pertussis Isolates Circulating for the Last 10 Years in France, Where a Single Effective Whole-Cell Vaccine Has Been Used for More than 30 Years . J Clin Microbiol 2001; 39(12): 4296-4403.

94 Bart MJ, van Gent M, van der Heide HGJ et al. Comparative genomics of prevaccination and modern Bordetella pertussis strains . BMC Genomics 2010; 11: 627.

95 Xu Y, Liu B et al. Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis . Sci Rep 2015; 5: 12888.

96 Mooi FR, van Loo IHM, van Gent M et al. Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence . Emerg Infect Dis 2009; 15(8): 1206-1213.

97 Kallonen T, He Q. Bordetella pertussis strain variation and evolution post vaccination. Expert Rev Vaccines 2009; 8(7): 863-875.


98 Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen . Infect Genet Evol 2010; 10(1): 36-49.

99 Guiso N, Hegerle N. Other Bordetellas, lessons for and from pertussis vaccines. Expert Rev Vaccines 2014; 13(9): 1125-1133.

100 Bouchez V, Hegerle N, Strati F et al.New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates. Vaccines (Basel) 2015; 3(3): 751-770.

101 Mooi FR, van Loo IHM, van Gent M et al. Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence . Emerg Infect Dis 2009; 15(8): 1206-1213.

102 CDC. Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged

103 Healy CM, Rench MA, Wootton SH, Castagnini LA.Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J 2015; 34(1): 22-26.

104 NVIC. National Vaccine Information Center Supports Three of Five Recommendations of New IOM Report on U.S. Childhood Immunization Schedule Safety and Calls for Transparency. Businesswire Jan. 16, 2013.

105 Collins F. Resurgence of Measles, Pertussis Fueled by Vaccine Refusals . NIH Mar. 22, 2016.

106 Fisher BL. The Vaccine Culture War in America: Are You Ready? NVIC Newsletter Mar. 8, 2015.

107 NVIC. National Vaccine Information Center Says Proposed 21st Century Cures Act Will Endanger the Public Health by Lowering FDA Licensing Standards . Businesswire July 22, 2015.

108 Fisher BL. Vaccine Injury Compensation: Government’s Broken Social Contract with Parents. Nov. 2, 2015. NVIC Newsletter Nov. 2, 2016.

Posta un commento

Commenti

  • jean Paul Aggiunto MI dispiace ma non sono d'accordo ! la pertosse non si propaga....nell'aria....ma si autosomatizza quando il sistema immunitario e' leso dai precedenti vaccini !
    questi i gravi danni dei vaccini : http://www.mednat.org/vaccini/dannivacc.htm
RSS